Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation
A new catheter from Johnson & Johnson MedTech is now approved to treat cardiac arrhythmias in Europe. Could FDA approval be on the horizon?
Robotic mitral repair compares favorably to surgery—but some concerns remain
Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.
FDA has now cleared more than 1,000 AI models, including many in cardiology
Cardiology is the medical speciality with the second most FDA clearances overall.
Altered brain structure may play a role in eating disorders, MRI data suggest
Experts recently uncovered evidence suggesting behaviors such as undereating, binging and purging could be owed to anatomical alterations in parts of the brain.
Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.

How the 2022 contrast media shortage impacted stroke care

A team of specialists tracked CT utilization before, during and after the 2022 shortage, sharing its findings in the American Journal of Neuroradiology.

August 16, 2023

FDA clears 2 new AI models that help with the diagnosis and treatment of arrhythmias

The two algorithms are now commercially available on a price-per-use basis.

August 16, 2023

Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary.

August 16, 2023

Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Serious discrepancies between preliminary imaging reads and final radiology reports are at risk of accumulating when the prelims are rendered during overnight hours.

August 16, 2023

Male stroke patients undergo CTA at significantly higher rates than women with no impact on outcomes

The disparity appeared concentrated among white, privately insured, higher income, and middle aged (50-79 year-old) men.

August 15, 2023

doctor with overweight patient who may be treated with TAVR or surgery

Weight loss drug semaglutide could boost heart health of up to 93M patients in US alone

Researchers have recently determined that the medication, originally developed to treat diabetes, can contribute to weight loss and reduce a patient's MACE risk by up to 20%.

August 15, 2023

artificial intelligence robot evaluates healthcare data

AI model for HCM, the first of its kind, gains FDA approval

The new-look AI model was designed to automatically evaluate ECGs for signs of HCM and send alerts to the care team when necessary.

August 15, 2023

Shockwave Medical, the subject of recent acquisition rumors, announces $650M private offering

A majority of the proceeds raised would go toward "general corporate purposes," which could mean anything from research and development to investments in other healthcare companies.

August 14, 2023

Clinical

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation

Robotic mitral repair compares favorably to surgery—but some concerns remain

FDA has now cleared more than 1,000 AI models, including many in cardiology

Altered brain structure may play a role in eating disorders, MRI data suggest

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications